BEZAFIBRATE — all Canadian products
5 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is BEZAFIBRATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02083523 | BEZALIP SR | ALLERGAN INC | Tablet (Extended-Release) | Oral | BEZAFIBRATE 400 MG | Marketed | |
| 02453312 | JAMP-BEZAFIBRATE SR | JAMP PHARMA CORPORATION | Tablet (Extended-Release) | Oral | BEZAFIBRATE 400 MG | Marketed | |
| 02379414 | ACT-BEZAFIBRATE SR | ACTAVIS GROUP PTC EHF | Tablet (Extended-Release) | Oral | BEZAFIBRATE 400 MG | Cancelled Pre Market | |
| 02084082 | BEZALIP TAB 200MG | HOFFMANN-LA ROCHE LIMITED | Tablet | Oral | BEZAFIBRATE 200 MG | Cancelled Post Market | |
| 02240331 | PMS-BEZAFIBRATE | PHARMASCIENCE INC | Tablet | Oral | BEZAFIBRATE 200 MG | Cancelled Post Market |
Browse other molecules: